{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:18:29Z","timestamp":1767147509049,"version":"build-2238731810"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH Bioengineering Research Partnership","award":["EB002185"],"award-info":[{"award-number":["EB002185"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.jconrel.2012.10.021","type":"journal-article","created":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T03:46:24Z","timestamp":1352346384000},"page":"216-225","source":"Crossref","is-referenced-by-count":57,"title":["Ultrasound-based molecular imaging and specific gene delivery to mesenteric vasculature by endothelial adhesion molecule targeted microbubbles in a mouse model of Crohn's disease"],"prefix":"10.1016","volume":"165","author":[{"given":"Jos\u00e9 L.","family":"Tlaxca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua J.","family":"Rychak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter B.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasad R.","family":"Konkalmatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talent I.","family":"Shevchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa T.","family":"Pizzaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Rivera-Nieves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander L.","family":"Klibanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2012.10.021_bb0005","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ncpgasthep0528","article-title":"Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis","volume":"3","author":"Sartor","year":"2006","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0010","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.3748\/wjg.15.5377","article-title":"Genome-wide association studies\u2014a summary for the clinical gastroenterologist","volume":"15","author":"Melum","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0015","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1734-1140(11)70575-8","article-title":"Treatment of inflammatory bowel disease (IBD)","volume":"63","author":"Pithadia","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0020","first-page":"3204","article-title":"Current treatment of ulcerative colitis","volume":"17","author":"Meier","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0025","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn's disease","volume":"362","author":"Colombel","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0030","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1136\/gut.2005.089854","article-title":"Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial","volume":"55","author":"Van Assche","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2012.10.021_bb0035","first-page":"495","article-title":"Inflammatory bowel disorders: gene therapy solutions","volume":"5","author":"Wirtz","year":"2003","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nrgastro.2009.232","article-title":"The pharmacoeconomics of biologic therapy for IBD","volume":"7","author":"Cohen","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0045","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/S0002-9270(01)02494-7","article-title":"Integrating anti-tumor necrosis factor therapy in inflammatory bowel disease: current and future perspectives","volume":"96","author":"Blam","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0050","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrd2805","article-title":"Averting inflammation by targeting the cytokine environment","volume":"9","author":"Kopf","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/nrgastro.2009.218","article-title":"Future biologic targets for IBD: potentials and pitfalls","volume":"7","author":"Melmed","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2036.2009.04130.x","article-title":"The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies","volume":"31","author":"Allez","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0065","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nri2761","article-title":"Therapeutic antibodies for autoimmunity and inflammation","volume":"10","author":"Chan","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0070","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1471-4906(03)00117-0","article-title":"Leukocyte-endothelial cell interactions in leukocyte transmigration and the inflammatory response","volume":"24","author":"Muller","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0075","first-page":"97","article-title":"Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue","volume":"151","author":"Briskin","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0080","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1053\/j.gastro.2009.02.001","article-title":"Biological therapies for inflammatory bowel diseases","volume":"136","author":"Rutgeerts","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2012.10.021_bb0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/1756283X10373176","article-title":"Anti-adhesion molecule therapy for inflammatory bowel disease","volume":"3","author":"Ghosh","year":"2010","journal-title":"Therap. Adv. Gastroenterol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0090","doi-asserted-by":"crossref","DOI":"10.1152\/ajpgi.00423.2004","article-title":"Physiologic basis for novel drug therapies used to treat inflammatory bowel disease I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease","volume":"288","author":"Van Assche","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/mvre.1998.2132","article-title":"Expression of immunoglobulin superfamily members on the lymphatic endothelium of inflamed human small intestine","volume":"57","author":"Sawa","year":"1999","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0100","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/ibd.20501","article-title":"Leukocyte adhesion molecules in animal models of inflammatory bowel disease","volume":"14","author":"Rivera-Nieves","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.gastro.2005.11.009","article-title":"Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn's disease","volume":"130","author":"Bachmann","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2012.10.021_bb0110","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1292\/jvms.001553","article-title":"Pathomechanism of cellular infiltration in the perivascular region of several organs in the SAMP1\/Yit mouse","volume":"7","author":"Chosa","year":"2009","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0115","doi-asserted-by":"crossref","first-page":"921","DOI":"10.7863\/jum.2011.30.7.921","article-title":"A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature","volume":"30","author":"Warram","year":"2011","journal-title":"J. Ultrasound Med."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0120","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/01.CIR.0000080287.74762.60","article-title":"Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1","volume":"108","author":"Weller","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2012.10.021_bb0125","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.addr.2008.03.005","article-title":"Microbubbles in ultrasound-triggered drug and gene delivery","volume":"60","author":"Hernot","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0130","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.ultrasmedbio.2010.05.014","article-title":"Analysis of in vitro transfection by sonoporation using cationic and neutral microbubbles","volume":"36","author":"Tlaxca","year":"2010","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0135","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/01.CIR.0000084535.35435.AE","article-title":"Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart","volume":"108","author":"Bekeredjian","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2012.10.021_bb0140","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s11095-005-2586-7","article-title":"Intracellular delivery of Bak BH3 peptide by microbubble-enhanced ultrasound","volume":"22","author":"Kinoshita","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0145","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/CIRCRESAHA.107.148676","article-title":"Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle","volume":"101","author":"Leong-Poi","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0150","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2008.02.041","article-title":"Enhancing ultrasound-mediated cell membrane permeabilisation (sonoporation) using a high frequency pulse regime and implications for ultrasound-aided cancer chemotherapy","volume":"266","author":"Li","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0155","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jconrel.2005.01.011","article-title":"Ultrasound-mediated gene delivery: kinetics of plasmid internalization and gene expression","volume":"104","author":"Mehier-Humbert","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.10.021_bb0160","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0301-5629(99)00105-2","article-title":"Ultrasonic enhancement of gene transfection in murine melanoma tumors","volume":"25","author":"Miller","year":"1999","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0165","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jconrel.2008.09.088","article-title":"Nonviral delivery of siRNA into mesenchymal stem cells by a combination of ultrasound and microbubbles","volume":"133","author":"Otani","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.10.021_bb0170","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ultrasmedbio.2006.04.014","article-title":"Physical parameters affecting ultrasound\/microbubble-mediated gene delivery efficiency in vitro","volume":"32","author":"Rahim","year":"2006","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0175","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/S0301-5629(03)00976-1","article-title":"Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles","volume":"29","author":"Christiansen","year":"2003","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0180","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/lrb.2005.3.105","article-title":"Isolation and characterization of a novel mouse lymphatic endothelial cell line: SV-LEC","volume":"3","author":"Ando","year":"2005","journal-title":"Lymphat. Res. Biol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0185","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.4049\/jimmunol.180.4.2573","article-title":"A CD8+\/CD103high T cell subset regulates TNF-mediated chronic murine ileitis","volume":"180","author":"Ho","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0190","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jcis.2008.09.066","article-title":"Microbubble size isolation by differential centrifugation","volume":"329","author":"Feshitan","year":"2009","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0195","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2009.08.001","article-title":"Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow","volume":"140","author":"Ferrante","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.10.021_bb0200","series-title":"Biomedical Aspects of Drug Targeting","first-page":"1","article-title":"Strategies and means for drug targeting: an overview","author":"Torchilin","year":"2010"},{"key":"10.1016\/j.jconrel.2012.10.021_bb0205","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/sj.gt.3301339","article-title":"Microbubble-enhanced ultrasound for vascular gene delivery","volume":"7","author":"Lawrie","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0210","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ultrasmedbio.2004.08.002","article-title":"Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction","volume":"31","author":"Bekeredjian","year":"2005","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0215","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0195-668X(03)00469-X","article-title":"Optimization of ultrasound-mediated gene transfer: comparison of contrast agents and ultrasound modalities","volume":"24","author":"Pislaru","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0220","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1067\/mje.2002.119913","article-title":"Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA","volume":"15","author":"Vannan","year":"2002","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0225","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1021\/la0603828","article-title":"Ultrasound-responsive polymer-coated microbubbles that bind and protect DNA","volume":"22","author":"Lentacker","year":"2006","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2012.10.021_bb0230","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jconrel.2011.09.071","article-title":"Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors","volume":"157","author":"Sirsi","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.10.021_bb0235","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.3171\/2010.11.JNS101201","article-title":"Inhibition of glioma growth by microbubble activation in a subcutaneous model using low duty cycle ultrasound without significant heating","volume":"114","author":"Burke","year":"2011","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0240","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1109\/TBME.2009.2030335","article-title":"Increasing the endothelial layer permeability through ultrasound-activated microbubbles","volume":"57","author":"Kooiman","year":"2010","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0245","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2011.04.008","article-title":"Sonoporation of endothelial cells by vibrating targeted microbubbles","volume":"154","author":"Kooiman","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.10.021_bb0250","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1124\/mi.6.2.7","article-title":"Advanced drug delivery systems that target the vascular endothelium","volume":"6","author":"Ding","year":"2006","journal-title":"Mol. Interv."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0255","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00441-008-0676-7","article-title":"Targeted delivery of therapeutics to endothelium","volume":"335","author":"Simone","year":"2009","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0260","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jconrel.2005.01.007","article-title":"Plasma membrane poration induced by ultrasound exposure: implication for drug delivery","volume":"104","author":"Mehier-Humbert","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.10.021_bb0265","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/1570161043385736","article-title":"Endothelial endocytic pathways: gates for vascular drug delivery","volume":"2","author":"Muro","year":"2004","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0270","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/RLI.0b013e3182034fed","article-title":"Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent","volume":"46","author":"Anderson","year":"2011","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0275","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/RLI.0b013e3181efd581","article-title":"scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis","volume":"45","author":"Anderson","year":"2010","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.jconrel.2012.10.021_bb0280","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2310\/7290.2007.00024","article-title":"Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis","volume":"6","author":"Rychak","year":"2007","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.jconrel.2012.10.021_bb0285","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/RLI.0b013e3181c5927c","article-title":"BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis","volume":"45","author":"Pochon","year":"2010","journal-title":"Invest. Radiol."}],"updated-by":[{"DOI":"10.1016\/j.jconrel.2013.10.028","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2014,1,10]],"date-time":"2014-01-10T00:00:00Z","timestamp":1389312000000}}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365912007535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365912007535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T07:00:49Z","timestamp":1562310049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365912007535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0168365912007535"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2012.10.021","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}